Noah Smith, Stephanie Sher, and Noor discuss modern dating, differences in women's and men's timelines for starting a family, resulting complications, and ways to make dating and finding a match easier.
The guide compares embryo screening with prenatal options, including non-invasive prenatal testing (NIPT), chorionic villus sampling (CVS), and amniocentesis, and discusses their capabilities and limitations.
The company reports that genetic risk scores (GRS) developed on large population datasets retain their effectiveness when comparing disease risk between embryos.
The guide compares Nucleus and Orchid's embryo screening services, describing one approach that analyzes embryo cells and another that analyzes existing embryo genetic data.
Screen embryos for 1,700+ genetic conditions before pregnancy. Orchid's whole genome screening reads 99% of an embryo's genome — 100x more data than standard PGT.
